32
Bauer, M., London, E.D., Silverman, D.H.S., Rasgon, N., Kirchheiner, J., Whybrow,
P.C., 2003. Thyroid, Brain and Mood Modulation in Affective Disorder: Insights from
Molecular Research and Functional Brain Imaging. Pharmacopsychiatry 36, 215-221.
Bauer, M., London, E.D., Rasgon, N., Berman, S.M,, Frye, M.A., Altshuler, L.L.,
Mandelkern, M.A., Bramen, J., Voytek, B., Woods, R., Mazziotta, J.C., Whybrow,
P.C., 2005. Supraphysiological doses of levothyroxine alter regional cerebral
metabolism and improve mood in bipolar depression. Mol Psychiatry. 10(5), 456-469.
Bauer, M., Goetz, T., Glenn, T., Whybrow, P.C., 2008. The thyroid-brain interaction in
thyroid disorders and mood disorders. J Neuroendocrinol. 20(10), 1101-1114.
Chueire, V.B., Silva, E.T.B., Perotta, E., Romaldini, J.H., Ward, L.S., 2003. High
serum TSH levels are associated with depression in the elderly. Arch Gerontol
Geriatr 36, 281-288.
Cleare, A.J., McGregor, A., O'Keane, V., 1995. Neuroendocrine evidence for an
association between hypothyroidism, reduced central 5-HT activity and depression.
Clin Endocrinol. 43, 713-719.
Cleare, A.J., McGregor, A., Chambers, S.M., Dawling, S., O'Keane, V., 1996.
Thyroxine replacement increases central 5-hydroxytryptamine activity and reduces
depressive symptoms in hypothyroidism. Clin Endocrinol. 64, 65-69.
Cloninger, C.R., Svrakic, D.M., Przybeck, T.R., 1993. A psychobiological model of
temperament and character. Arch. Gen. Psychiatry 50, 975-990.
Cooper-Kazaz, R., Apter, J.T., Cohen, R., Karagichev, L., Muhammed-Moussa, S.,
Grupper, D., Drori, T., Newman, ME., Sackeim, H.A., Glaser, B., Lerer, B., 2007.
Combined treatment with sertraline and liothyronine in major depression: a
randomized, double-blind, placebo-controlled trial. Arch Gen Psychiatry. 64(6), 679-
688.
Dong, B.J., 2000. How medications affect thyroid function. West J Med. 172(2), 102-
106.